| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |